352 related articles for article (PubMed ID: 21946303)
1. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
[TBL] [Abstract][Full Text] [Related]
2. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis.
Alkim H; Ayaz S; Sasmaz N; Oguz P; Sahin B
Clin Appl Thromb Hemost; 2012 Jul; 18(4):409-15. PubMed ID: 22166587
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
5. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
7. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.
Jansen JO; Scarpelini S; Pinto R; Tien HC; Callum J; Rizoli SB
J Trauma; 2011 Nov; 71(5 Suppl 1):S435-40. PubMed ID: 22072000
[TBL] [Abstract][Full Text] [Related]
8. Postoperative changes in procoagulant factors after major surgery.
Lison S; Weiss G; Spannagl M; Heindl B
Blood Coagul Fibrinolysis; 2011 Apr; 22(3):190-6. PubMed ID: 21245747
[TBL] [Abstract][Full Text] [Related]
9. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
Chen H; Qi X; He C; Yin Z; Fan D; Han G
Thromb Res; 2013 Feb; 131(2):173-7. PubMed ID: 23157737
[TBL] [Abstract][Full Text] [Related]
10. Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.
Rossetto V; Spiezia L; Senzolo M; Rodriguez K; Gavasso S; Woodhams B; Simioni P
Int J Lab Hematol; 2013 Feb; 35(1):101-5. PubMed ID: 22958499
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.
Delahousse B; Labat-Debelleix V; Decalonne L; d'Alteroche L; Perarnau JM; Gruel Y
Thromb Haemost; 2010 Oct; 104(4):741-9. PubMed ID: 20806106
[TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
[TBL] [Abstract][Full Text] [Related]
13. Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients.
Pinazo MJ; Tàssies D; Muñoz J; Fisa R; Posada Ede J; Monteagudo J; Ayala E; Gállego M; Reverter JC; Gascon J
Thromb Haemost; 2011 Oct; 106(4):617-23. PubMed ID: 21866301
[TBL] [Abstract][Full Text] [Related]
14. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
17. Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy.
Mejía JC; Espinosa G; Tàssies D; Reverter JC; Cervera R
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S67-71. PubMed ID: 25068444
[TBL] [Abstract][Full Text] [Related]
18. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of pro- vs. anti-coagulation factors in Chinese patients with Budd-Chiari syndrome and non-cirrhotic portal vein thrombosis.
Chen H; Liu L; Qi X; He C; Yin Z; Wu F; Fan D; Han G
PLoS One; 2015; 10(3):e0119909. PubMed ID: 25823002
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
